These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11992680)

  • 41. Disposition of lipid-based formulation in the intestinal tract affects the absorption of poorly water-soluble drugs.
    Iwanaga K; Kushibiki T; Miyazaki M; Kakemi M
    Biol Pharm Bull; 2006 Mar; 29(3):508-12. PubMed ID: 16508155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
    Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
    Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ultra-performance liquid chromatography-tandem mass spectrometry method for the determination of nitrendipine in dog plasma and its application to a pharmacokinetic study of a solid self-emulsifying pellet formulation.
    Liu Y; Wang Z; Sun J; Wang Y; He Z
    Arzneimittelforschung; 2011; 61(12):674-80. PubMed ID: 22282953
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thermal reversible microemulsion system for poorly water-soluble YH439 for oral delivery.
    Han DH; Jin ZH; Jin YZ; Yin XZ; Shen YY; Gao ZG
    Chem Pharm Bull (Tokyo); 2010 Jan; 58(1):11-5. PubMed ID: 20045958
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decrease of genital organ weights and plasma testosterone levels in rats following oral administration of leuprolide microemulsion.
    Zheng JY; Fulu MY
    Int J Pharm; 2006 Jan; 307(2):209-15. PubMed ID: 16300912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development and mechanistic study of a microemulsion containing vitamin E TPGS for the enhancement of oral absorption of celecoxib.
    Subongkot T
    Int J Nanomedicine; 2019; 14():3087-3102. PubMed ID: 31118624
    [No Abstract]   [Full Text] [Related]  

  • 48. Development and in vitro-in vivo evaluation of a water-in-oil microemulsion formulation for the oral delivery of troxerutin.
    Xu M; Yu Q; Zhao Q; Chen W; Lin Y; Jin Y
    Drug Dev Ind Pharm; 2016; 42(2):280-7. PubMed ID: 26165244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Examination of lymphatic transport of puerarin in unconscious lymph duct-cannulated rats after administration in microemulsion drug delivery systems.
    Wu H; Zhou A; Lu C; Wang L
    Eur J Pharm Sci; 2011 Mar; 42(4):348-53. PubMed ID: 21216284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and evaluation of ibuprofen-loaded microemulsion for improvement of oral bioavailability.
    Hu L; Yang J; Liu W; Li L
    Drug Deliv; 2011 Jan; 18(1):90-5. PubMed ID: 20942639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides.
    Constantinides PP; Scalart JP; Lancaster C; Marcello J; Marks G; Ellens H; Smith PL
    Pharm Res; 1994 Oct; 11(10):1385-90. PubMed ID: 7855039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vivo evaluation of two novel controlled-release nitrendipine formulations.
    Yang M; Cui F; You B; Yang M; Tao A; Cun D; Kawashima Y
    Drug Dev Ind Pharm; 2005 Aug; 31(7):589-95. PubMed ID: 16207605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery.
    Cao M; Ren L; Chen G
    AAPS PharmSciTech; 2017 Aug; 18(6):1960-1971. PubMed ID: 27914040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral delivery of a renin inhibitor compound using emulsion formulations.
    Kararli TT; Needham TE; Griffin M; Schoenhard G; Ferro LJ; Alcorn L
    Pharm Res; 1992 Jul; 9(7):888-93. PubMed ID: 1438002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of surfactants in self-microemulsifying formulations on enhancing oral bioavailability of oxyresveratrol: Studies in Caco-2 cells and in vivo.
    Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Graidist P; Wiwattanapatapee R
    Int J Pharm; 2016 Feb; 498(1-2):294-303. PubMed ID: 26680318
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transformation of poorly water-soluble drugs into lipophilic ionic liquids enhances oral drug exposure from lipid based formulations.
    Sahbaz Y; Williams HD; Nguyen TH; Saunders J; Ford L; Charman SA; Scammells PJ; Porter CJ
    Mol Pharm; 2015 Jun; 12(6):1980-91. PubMed ID: 25905624
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study.
    Shah N; Seth A; Balaraman R; Sailor G; Javia A; Gohil D
    Drug Dev Ind Pharm; 2018 Apr; 44(4):687-696. PubMed ID: 29168671
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development.
    Kataoka M; Sugano K; da Costa Mathews C; Wong JW; Jones KL; Masaoka Y; Sakuma S; Yamashita S
    Pharm Res; 2012 Jun; 29(6):1485-94. PubMed ID: 22134778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.